Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive (Loss) Income	Accumulated Deficit	Noncontrolling Interest
Balance, shares at Dec. 31, 2022		35,907,127
Balance, amount at Dec. 31, 2022	$ 9,817,461	$ 359,071	$ 16,756,426	$ 255,030	$ (7,553,066)	$ 0
Issuance of common stock, net of issuance costs, shares		13,117,067
Issuance of common stock, net of issuance costs, amount	13,566,022	$ 131,171	13,434,851	0	0	0
Issuance of common stock for non-cash issuance costs, shares		472,582
Issuance of common stock for non-cash issuance costs, amount	0	$ 4,726	(4,726)	0	0	0
Issuance of common stock to settle share liability, shares		150,000
Issuance of common stock to settle share liability, amount	228,000	$ 1,500	226,500
Settlement of liability with related parties	626,223	$ 0	626,223	0	0	0
Settlement of liability with consultants, shares		519,750
Settlement of liability with consultants, amount	776,695	$ 5,198	771,497	0	0	0
Cancellation of common stock received in exchange for issuance of convertible preferred stock in subsidiary, shares		(3,000,000)
Cancellation of common stock received in exchange for issuance of convertible preferred stock in subsidiary, amount	0	$ (30,000)	30,000	0	0	0
Issuance of restricted shares, shares		1,756,750
Issuance of restricted shares, amount	0	$ 17,567	(17,567)	0	0	0
Stock-based compensation	8,743,799	0	8,743,799	0	0	0
Noncontrolling interest in ASP Rentals	721,548	0	0	0	0	721,548
Acquisition of PET Labs	1,821,021	0	0	0	0	1,821,021
Foreign currency translation	(1,176,012)	0	0	(1,176,012)	0	0
Net loss	(16,294,126)	$ 0	0	0	(16,286,234)	(7,892)
Balance, shares at Dec. 31, 2023		48,923,276
Balance, amount at Dec. 31, 2023	18,830,631	$ 489,233	40,567,003	(920,982)	(23,839,300)	2,534,677
Issuance of common stock, net of issuance costs, shares		16,554,250
Issuance of common stock, net of issuance costs, amount	49,442,802	$ 165,542	49,277,260	0	0	0
Issuance of common stock from warrant exercise, shares		3,316,298
Issuance of common stock from warrant exercise, amount	5,837,663	$ 33,163	5,804,500	0	0	0
Issuance of common stock to consultant, shares		60,000
Issuance of common stock to consultant, amount	$ 183,600	$ 600	183,000	0	0	0
Issuance of restricted common stock to consultant, shares	150,000
Issuance of common stock to board members, shares		670,681
Issuance of common stock to board members, amount	$ 0	$ 6,707	(6,707)	0	0	0
Retired unvested restricted shares, shares		(325,000)
Retired unvested restricted shares, amount	0	$ (3,250)	3,250	0	0	0
Settlement of liability with consultants, shares		345,000
Settlement of liability with consultants, amount	1,154,850	$ 3,450	1,151,400	0	0	0
Issuance of restricted shares, shares		2,523,554
Issuance of restricted shares, amount	0	$ 25,236	(25,236)
Board fee liabilities settled with shares	240,000	$ 0	240,000	0	0	0
Commission fee liability settled with cash and common stock warrant	(1,006,763)		(1,006,763)	0	0	0
Settlement of commission fee liability payable in common stock warrant	765,894		765,894	0	0	0
Stock-based compensation	8,561,404		8,561,404	0	0	0
Contribution from noncontrolling interest in VIE	920,336		0	0	0	920,336
Distribution to noncontrolling interest of VIE	(97,918)		0	0	0	(97,918)
Foreign currency translation	(1,243,331)		0	(1,243,331)	0	0
Net loss	(32,422,728)		0	0	(32,333,581)	(89,147)
Balance, shares at Dec. 31, 2024		72,068,059
Balance, amount at Dec. 31, 2024	$ 51,166,440	$ 720,681	$ 105,515,005	$ (2,164,313)	$ (56,172,881)	$ 3,267,948